Caracterização clínica, anatomopatológica e imuno-histoquímica dos cânceres de mama diagnosticados em mulheres no município de Chapecó/SC

Abstract

INTRODUCTION: Breast cancer (BC) is the most frequent type of cancer in Brazilian women, presenting complex variables, influenced by both endogenous and exogenous factors. Due to its earlier incidence, screening and diagnosis are important for therapeutic success and greater survival at the end of treatment. The best anatomopathological and anatomopathological characterization of CM is used to worsen treatment, in addition to prognosis. The following work aims to characterize the clinical profile of patients as well as the anatomopathological and immunohistochemical data of MC as objectives in the municipality of Chapecó - SC. METHODOLOGY A clinical and data study, both data, presented in medical records of patients treated in complementary health records, diagnoses under the ICD CID50 and tests and the years of surgical treatment, between the years 2015 and 2019. The review was carried out by electronic medical records that contained useful information for later analysis through the Chi-square test via SPSS 25.0 software, considering a 95% confidence interval and significant results when the p value was less than 0.05. RESULTS AND DISCUSSION: In total, data were received from 152 patients, 85 of whom were treated in the SUS and 67 in a supplementary health service. The most prevalent immunohistochemical type in the sample was Luminal A (28.7%), followed by Luminal B (23.8%). Among the age group aged 40 to 49 years without diagnosis, the Luminal B type predominated (42.9%). As for the age group of patients aged 50 years or older, there was a prevalence of Luminal A type (44.9%). The most frequent histological type in all age groups was invasive ductal carcinoma (70.5%). It should also be noted that the MC of patients treated less by complementary health services (private and health insurance) were diagnosed at an advanced stage of the disease, when compared with patients treated by the SUS.